SYNAREL

This brand name is authorized in Australia, Canada, Spain, France, Ireland, Israel, Netherlands, Turkey, United Kingdom, United States

Active ingredients

The drug SYNAREL contains one active pharmaceutical ingredient (API):

1 Nafarelin
UNII 8ENZ0QJW4H - NAFARELIN ACETATE

Nafarelin is a potent agonistic analogue of gonadotrophin releasing hormone (GnRH). Given as a single dose, nafarelin stimulates release of the pituitary gonadotrophins, LH and FSH, with consequent increase of ovarian and testicular steroidogenesis.

Read about Nafarelin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SYNAREL Nasal spray, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
H01CA02 Nafarelin H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CA Gonadotropin-releasing hormones
Discover more medicines within H01CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 2962X, 5815C
Country: CA Health Products and Food Branch Identifier(s): 02188783
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 60079
Country: FR Base de données publique des médicaments Identifier(s): 63954950
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 38228
Country: IE Health Products Regulatory Authority Identifier(s): 88190
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4996
Country: NL Z-Index G-Standaard Identifier(s): 14243660
Country: NL Z-Index G-Standaard, PRK Identifier(s): 51675
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699543540023
Country: US FDA, National Drug Code Identifier(s): 0025-0166

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.